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Nuclear factor jB is required for the transcriptional control of type II NO
synthase in regenerating liver
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A concerted activation of transcription factors involved in the
transactivation of type II NO synthase (iNOS) gene occurred
after partial hepatectomy (PH), resulting in the transient ex-
pression of iNOS. The corresponding mRNA and protein levels
of iNOS reached a maximum at 4 h and 8 h post-PH respectively.
This induction was preceded by an early and transient activation
of nuclear factor jB (NF-jB). Analysis of the jB inhibitory (I)
proteins showed an important role for IjBa in the process of NF-
jB activation, whereas the contribution of IjBb was less evident.
Interferon regulatory factor 1, which has been described as an
important activator of iNOS expression, was up-regulated after
PH but failed to bind to the corresponding DNA binding
INTRODUCTION
In the aftermath of liver injury by surgical resection of different
portions of tissue, the remnant liver initiates a series of reactions
in an attempt to re-establish the hepatic-dependent homoeostasis
in the organism and to promote cell growth to achieve restored
liver function [1–4]. A great effort has been devoted to the
identification of the primary stimuli that switch-on the re-
generative process, and the view emerging from these studies is
that there exists a complex network of interactions, which
ultimately modulate a fine balance between factors compromised
with cell proliferation, growth-arrest and differentiation [5–7].
Among the multiple changes observed in the immediate hours
following partial hepatectomy (PH), an induction of type II NO
synthase (iNOS) and the release of NO in io have been reported
[8,9]. The expression of iNOS has been better characterized in
murine cells than in rat or humans, and for this reason we have
used a murine PH model to address the study of the molecular
basis of iNOS expression in the remnant liver [8,10,11]. Also,
because iNOS is expressed in liver in response to other systemic
stresses such as endotoxin treatment, we examined both con-
ditions to determine whether some responses are specific to each
type of liver insult [12].
A 1.8 kb fragment of the promoter region of the murine iNOS
gene has been cloned [10,11]. Analysis of the transcriptional
activity of this promoter using deletional mutants revealed the
essential role of the jB motifs in the control of iNOS expression
[9,10,13,14]. Indeed, a rapid nuclear factor jB (NF-jB) activation
has been reported in the liver remnant after PH [3,6]. For this
reason, the analysis of NF-jB activation is important to establish
the mechanisms that control iNOS expression in the course of
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sequences of the iNOS promoter. The transcriptional control of
iNOS after PH, was compared with the events associated with
the hepatic expression of this enzyme in animals challenged with
lipopolysaccharide, showing a differential pattern of tran-
scription-factor activation and IjB degradation between both
models. Transfection of hepatoma cell lines with iNOS promoter
constructs, followed by stimulation with post-PH sera, revealed
the requirement of NF-jB activation for iNOS expression. These
data suggest that there is an important role for the restricted NF-
jB activation in the temporal pattern of iNOS expression in
regenerating liver.
liver regeneration after PH. NF-jB consists of a heterodimeric
complex composed of two subunits of the NF-jB}c-Rel family,
usually p50 and p65, which are retained in the cytoplasm as an
inactive complex through the interaction with IjB inhibitory (I)
proteins [15,16]. A specific regulation by extracellular factors of
the IjBa and IjBb isoforms has been reported, which in turn
defines the temporal activation span of the NF-jB complex [17].
Our results show that iNOS is effectively induced in the remnant
liver of partially hepatectomized mice, but this response is
quantitatively lower than that elicited in animals treated with
lipopolysaccharide (LPS). Regarding the transcriptional factors
engaged in each model of iNOS induction, specificity exists in the
hepatic response, depending on the mechanism of liver injury.
MATERIALS AND METHODS
Chemicals
Chemicals and biochemicals were from Sigma (St. Louis, MO,
U.S.A.). Materials and chemicals for electrophoresis were from
Bio-Rad (Richmond, CA, U.S.A.). LPS was from Salmonella
typhimurium.
PH
Male Balb}c mice (25–30 g), maintained free of pathogens and
fed ad libitum, were used. Liver resection was performed under
light ether anaesthesia, and represented two-thirds of the mass of
tissue. To maintain the same stress between the distinct animal
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groups, surgery was carried out in 7 min for both sham and
hepatectomized animals [8]. Sera from mice was obtained by
cardiac puncture.
Animal treatment
Endotoxin administration was performed by intraperitoneal
injection of 0.5 ml of a solution containing LPS from S.
typhimurium (1 mg}kg body weight) in saline. Animals were
killed at different times and liver extracts were prepared im-
mediately.
Cell cultures
The murine hepatic cell line AT3F was derived from the tumorous
liver of transgenic mice expressing the SV40 early genes under
the direction of the liver-specific antithrombin III promoter [18].
The cells were maintained in Ham-F-12}Dulbecco’s modified
Eagle’s medium supplemented with antibiotics and 10% (v}v)
fetal-calf serum. When cells were stimulated with mice serum, the
dishes were washed twice with PBS and incubated in the absence
of serum 14 h before mice serum addition.
Plasmids and transfection assays
A 1749 bp HincII fragment, corresponding to the 5«-flanking
region of murine iNOS [10] fused to a promoterless chloram-
phenicol acetyltransferase (CAT) reporter gene (pNOS-CAT),
was generously given by Dr. Q.-w. Xie and C. Nathan (Cornell
University, Ithaca, NY, U.S.A.). A plasmid construct
[pNOS(jB−,−)-CAT vector] in which the two jB sites were
mutated (nucleotides ®971 to ®961 and ®85 to ®75 respect-
ively) was generated by PCR using oligonucleotide primers in
which the GGG motif of the jB site was substituted by a CCG
(donated by Dr. T. J. Evans; Royal Postgraduate Medical
School, London [14]). AT3F hepatocytes were transfected using
DOTAP (Boehringer) as described by the manufacturer. Upon
transfection, the cells were maintained for 14 h with culture
medium, followed by stimulation with serum from control, sham
or hepatectomized animals (10%). After 24 h of incubation,
CAT activity was measured [18].
Preparation of total RNA and Northern blot analysis
Total cellular RNA was prepared from small, liquid-N
#
-frozen
portions of liver (50–100 mg of tissue) following the guanidinium
isothiocyanate method [19]. Aliquots of RNA (20–35 lg) were
size-separated by electrophoresis on a 0.9% (w}v) agarose gel,
and transferred to Nytran membranes (NY 13-N; Schleicher &
Schu$ ell) [20]. An 817 bp fragment (nucleotides 1–817) from the
cDNA of macrophage iNOS was random-primed labelled with
the Rediprime kit from Amersham (Amersham, Bucks, U.K.)
and was used to detect the level of transcription [8]. A
BamHI}HindIII fragment of 1.4 kb of the cDNA of IjBa was
used as a probe to detect the mRNA levels and was generously
given by Dr. J. Moscat (Universidad, Auto! noma, Madrid, Spain)
[21]. A 420 bp fragment of IjBb was synthesized by reverse-
transcriptase PCR, using samples of RNA obtained from testis,
due to the relative abundance in this tissue [17], and cloned
into a pGEM-T vector (Promega). The oligonucleotide primer
sequences were 5«-GGACACAGCCCTGCACTTGG-3« (oligo-
nucleotides 247–266) and 5«-GTAGCCTCCAGTCTTCATCA-
3« (oligonucleotides 668–649) from the published murine cDNA
sequence (DDBJ}EMBL}GenBank Nucleotide Sequence Data-
bases accession number U19799). After hybridization with the
probes, the membranes were exposed to a micrograph film
(Hyperfilm, Amersham). Quantification of the film was per-
formed by laser densitometry (Molecular Dynamics) using the
hybridization with a ribosomal 18 S probe as internal control.
Preparation of cytosolic and nuclear extracts
A modified procedure based on the method of Costa et al. was
used [22]. The tissue (100 mg) was homogenized at 4 °C in a
Dounce homogenizer in 8 vol. (w}v) of buffer A [10 mM Hepes
(pH 7.9)}1 mM EDTA}1 mM EGTA}10 mM KCl}1 mM
dithioerythritol}0.5 mM PMSF}aprotinin (2 lg}ml)}leupeptin
(10 lg}ml)}7-amino-1-chloro-3-l-tosylamidoheptan-2-one







0.15 mM spermine}0.5 mM spermidine}0.5 M sucrose}trypsin
inhibitor (50 lg}ml)]. After 10 min of incubation in an ice-bath
Nonidet P40 was added to reach 0.5% (v}v) final concentration.
The tubes were vortexed for 15 s and nuclei were sedimented by
centrifugation at 800 g for 15 min. Aliquots of the supernatant
were stored at ®80 °C (cytosolic extract), and the nuclei pellet
was washed twice with buffer A lacking detergent, and finally
resuspended in 250 ll of buffer A supplemented with 20% (v}v)
glycerol and 0.4 mM KCl. The incubation was followed for
30 min at 4 °C with gentle vortexing. Nuclear proteins were
extracted by centrifugation at 13000 g for 15 min and aliquots of
the supernatant were stored at ®80 °C. Proteins were measured
using the Bio-Rad protein reagent.
Electrophoretic mobility-shift assays (EMSAs)
Synthetic oligonucleotides were prepared using a Pharmacia
oligonucleotide synthesizer : NF-jB
p
, corresponding to the
proximal jB motif of the iNOS promoter [10,11] 5«-CCAACT-
GGGGACTCTCCCTTTGGGAACA-3« ; interferon regulatory
factor 1 (IRF-1), corresponding to the IRF-1 motif of the murine
iNOS promoter 5«-TCGACACTGTCAATATTTCACTTTCA-
TAA-3« ; sis inducible element (SIE), corresponding to the high-
affinity SIE m67 site [23] 5«-GACAGTTCCCGTCAATC-3« ;
AP-1 (consensus), corresponding to the AP-1 motif of the
albumin promoter [24] 5«-TTCCAAAGAGTCATCAG-3«. The
oligonucleotides were annealed and end-labelled with the Klenow
enzyme fragment in the presence of 50 lCi of [a-$#P]dCTP, and
the other unlabelled dNTP in a final volume of 50 ll [21]. The
DNA probes (5¬10% d.p.m.) were incubated for 30 min at 4 °C
with 5 lg of protein extract and 1 lg of poly(dI-dC)}ml, 5%
glycerol}1 mM EDTA}100 mM KCl}5 mM MgCl
#
}1 mM
dithiothreitol}10 mM Tris}HCl, pH 7.8, in a final volume of
20 ll. The incubation mixtures were processed by SDS}PAGE as
described previously [21]. Analysis of competition with unlabelled
oligonucleotides was performed using a 20-fold excess of double-
stranded DNA in the binding reaction, and adding the nuclear
extracts as the last step in the binding assay. Supershift assays
were carried out after addition of the antibody (0.5 lg) to the
binding reaction and incubation for 1 h at 4 °C [22]. Anti-p50
(human), anti-p65 (human) and anti-c-Rel (human) were gen-
erously given by Dr. N. R. Rice (National Cancer Institute,
Frederick, MD, U.S.A.). Anti-IRF-1 (mice) was from Santa
Cruz Biotechnology, Santa Cruz, CA, U.S.A.
Western blot analysis
Cytosolic and nuclear extracts were obtained as described
previously for the EMSAs. Proteins (30 lg and 10 lg per lane for
cytosolic and nuclear extracts respectively) were size-separated in
SDS}10% PAGE. The gels were processed as recommended by
the supplier of the antibodies (anti-iNOS from Transduction
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Laboratories ; anti-IjBa, anti-IjBb and anti-IRF-1 from Santa
Cruz Laboratories). After blotting onto a polyvinylidene
fluorescein membrane (Millipore) proteins were revealed fol-
lowing the enhanced chemiluminescence technique (Amersham).
Statistical analysis
Results are means³S.E.M. of the indicated number of experi-
ments. Statistical significance was estimated using Student’s t test
for unpaired observations. A P value of less than 0.05 was
considered to be significant.
RESULTS
iNOS expression in the remnant liver is preceded by NF-jB
activation
To identify the transcription factors relevant for the expression
of iNOS in animals that underwent PH, a timed programme of
surgery was carried out and the levels of iNOS mRNA were
followed by Northern blot analysis. As Figure 1(left) shows that
the maximal iNOS mRNA levels (4.5 kb band) were observed 4 h
after hepatectomy, followed by a drop in the steady-state levels
after 8 h, and are virtually undetectable at 18 or 24 h post-PH.
The protein levels were measured by Western blot using an
antibody specific for iNOS. As Figure 1(right) shows, the
maximal protein content was observed 8 h after PH and pro-
gressively decreased (29% of the maximal content after 24 h).
These results extend to the mouse, the previous observation of
iNOS induction after PH in the rat [8,9]. To address whether this
iNOS expression correlates with a NF-jB activation, the binding
of nuclear proteins to the jB sequences of the iNOS promoter
was assayed. As Figure 2 shows, an intense peak of binding of
nuclear proteins to the proximal jB sequence was observed 1 h
after PH, followed by a marked decrease in the intensity of the
bands. On analysis, the bands included p50–p50 homodimers
that were always present, and p50–p65 heterodimers that were
transiently induced after PH. This NF-jB activation was specific,
since in sham-operated animals the band pattern was virtually
Figure 1 iNOS mRNA and protein levels after 2/3 PH
Mice were partially hepatectomized and samples of the remnant liver were analysed for the iNOS
mRNA and protein levels. Results are means³S.E.M. of four samples after normalization for
the ribosomal 18 S content (left panel) or the mean³S.E.M. of three experiments for the
immunodetected iNOS by Western blot analysis (right panel). *P ! 0.001 compared with
samples at 0 h.
Figure 2 NF-jB is transiently activated after PH
Nuclear extracts from mice that underwent PH, sham, or intraperitoneal treatment with LPS were
assayed using as probe the jB sequence of the murine iNOS promoter. Only two bands were
detected and corresponded to p50–p50 (open bars) and p50–p65 (cross-hatched bars)
complexes. Results show the densitometric analysis of the bands (³S.E.M.) corresponding to
three experiments. *P ! 0.01 compared with samples from the control condition.
identical with that of the controls. Because iNOS is highly
expressed in the liver of animals intraperitoneally injected with
LPS, experiments were undertaken to compare the activation
process in the course of endotoxin treatment with that of PH.
LPS treatment of mice elicited a higher increase in p50–p65 than
after PH (Figure 2). Several dosages of in io administration of
LPS were tested, obtaining the maximal iNOS expression and
animal viability when used at 1 mg}kg body weight [25]. The
maximal ratios corresponding to the [p50–p65]}[p50–p50] bands
were 0.34 and 2.20 for PH-and LPS-treated animals respectively.
Characterization of the IjB proteins implicated in NF-jB
activation in regenerating liver
The activation of NF-jB is largely dependent on the dissociation
between the proteins of the c-Rel family and the inhibitory
proteins termed IjB. The characterization of the changes in
IjB proteins is of interest because the extent of the biological
response in which NF-jB activation is involved depends on the
time-course of IjB resynthesis [15–17]. For this reason, IjBa and
IjBb were analysed both at the mRNA and the protein levels. As
Figure 3 shows, the levels of IjBa mRNA in the remnant liver
after PH progressively increased to double at 6 h. However, in
animals treated with LPS this up-regulation of the mRNA levels
was more rapid (maximum at 1 h) and higher (4.7-fold increase)
than in the hepatectomized animals. Regarding the protein levels
(Figure 3, right) a decrease of IjBa was observed in hepatecto-
mized animals during the initial 6 h, followed by a recovery when
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Figure 3 IjBa protein levels decrease after PH
The mRNA levels and the amount of protein corresponding to IjBa in animals after PH or
intraperitoneal injection with LPS were determined in liver at the indicated times. Normalization
for RNA lane charge in the Northern blot was carried out after hybridization of the membrane
with a ribosomal 18 S probe. No significant changes were observed in sham animals. Results
are means³S.E.M. of three experiments. *P ! 0.05 compared with samples at 0 h.
Figure 4 IjBb protein is rapidly down-regulated in the liver of LPS-treated
animals
The mRNA levels and protein content of IjBb were determined at the indicated times. The
Northern blot was normalized after hybridization with a ribosomal 18 S probe. Results are
means³S.E.M. of three experiments. *P ! 0.05 compared with samples at 0 h.
assayed in the remnant liver 24 h after PH. When this protein
was analysed in animals treated with LPS, a 2.2-fold accumu-
lation was observed at 3 h, followed by a recovery of the basal
levels at 24 h.
When IjBb was studied (Figure 4), the amount of mRNA
nearly doubled 1 h after PH, and remained higher than the
control for up to 24 h after PH. However, in animals intra-
peritoneally injected with LPS, the mRNA levels remained
essentially stable during 3 h, with a 175% increase at 6 h. The
IjBb protein levels of PH animals exhibited a moderate decrease
(25%) at 1 h, followed by a progressive increase (175%) at 24 h.
However, in animals treated with LPS, an important decrease in
IjBb (more than 90% of the control) was observed at 1 h,
followed by a recovery at 3 h, and reaching the values of
Figure 5 IRF-1 analysis in the remnant liver after PH
Nuclear extracts from animals hepatectomized or intraperitoneally injected with LPS were
incubated with an oligonucleotide sequence containing the IRF-1 motif of the iNOS promoter
(right arrowhead). To assess the specificity of the binding, incubation of the extracts with anti-
IRF-1 antibody completely displaced the binding to the sequence of the arrow-indicated band
(A). The amount of IRF-1 in cytosolic liver extracts was determined by Western blot using the
same antibody as in the supershift assay (B).
hepatectomized animals at 6 h. These results suggest the existence
in the liver of a differential regulation of IjBa and IjBb
degradation and resynthesis, and therefore of the control of NF-
jB activation, in response to distinct stimuli.
Characterization of nuclear factors potentially involved in iNOS
expression
In addition to the analysis of NF-jB activation after PH, the
binding of proteins to motifs present in the murine iNOS
promoter was studied by EMSAs. The sequences used were the
SIE element and the IRF-1 and AP-1 binding sites. An important
synergism between the IRF-1 and the distal NF-jB motifs of the
murine iNOS promoter has been described previously [10,11,13].
As Figure 5(A) shows, a specific band displaced by anti-IRF-1
antibody was detected in nuclear extracts of animals treated for
1 h with LPS. However, absence of specific binding was observed
in nuclear extracts from remnant liver after PH. The nature of
the specific band detected after LPS challenge agrees with the
binding profile described in other cases, such as the LPS-
dependent activation of the murine interleukin-10 promoter [26].
Interestingly, murine liver contains an important amount of
IRF-1 that is slightly up-regulated in hepatectomized animals (at
3 and 6 h), and more intensely in LPS-treated animals (Figure
5B). The absence of IRF-1 binding to its sequence after PH
might be due to the inability of this transcription factor to
overpass the levels of IRF-2, which acts as a repressor and which
is largely expressed in liver [27].
AP-1 activation was observed in samples 1 h after PH, and
exhibited a maximum at 6 h (Figure 6). In animals treated with
LPS the maximum was obtained at 1 h, but significant levels
were still evident after 6 h. When the binding of nuclear proteins
to the SIE motif was measured, an increase was observed in
samples obtained 3 h after PH, whereas in animals treated with
LPS, this binding was observed at 1 h and extended for longer
periods (Figure 6). Since the synthesis of IRF-1 is regulated,
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Figure 6 Binding of AP-1 and SIE to consensus motifs by EMSA
Hepatic nuclear extracts from animals that underwent PH or intraperitoneal injection with LPS
were prepared at the indicated times and incubated with oligonucleotide sequences containing
the AP-1 and SIE binding motifs. Results show a representative experiment out of four.
among other mechanisms, through the activation of SIE motifs
in the promoter region of the gene [28], the up-regulation of
IRF-1 in hepatectomized or LPS-treated animals (Figure 5B) is
in agreement with the enhanced levels of binding to SIE motifs
reported in Figure 6.
Figure 7 Post-hepatectomy serum stimulates iNOS promoter activity
The AT3F murine hepatoma cell line was transfected with a plasmid (pNOS-CAT) harbouring a 1.8 kb fragment of the iNOS promoter (left panel) or a plasmid [pNOS(jB−,−)-CAT] with the two
jB sites mutated (right panel). The cells were incubated with 10% (v/v) serum from hepatectomized (solid bars) or sham (open bars) animals, and CAT activity was measured after 24 h of incubation.
Insets shows the CAT activity (fold) of AT3F cells stimulated with serum of LPS-treated rats obtained at the indicated times ; C refers to control serum (hatched bars). Results are means³S.E.M.
of three experiments (left panel), or a representative experiment (right panel) after normalization for the efficiency of the transfection [18,37]. *P ! 0.05 ; **P ! 0.01 compared with samples at
0 h.
jB activation is required for the expression of iNOS by serum
from PH animals
The results described above show qualitative and quantitative
differences in the temporal pattern of activation of transcriptional
factors that bind to the iNOS promoter either in the liver of two-
thirds hepatectomized animals or after intraperitoneal LPS
administration. To determine whether the expression of iNOS
after PH might be reproduced using an ex io system, AT3F
cells were transfected with a plasmid harbouring a 1.8 kb frag-
ment of the iNOS promoter linked to a CAT reporter gene, and
cells were stimulated with serum after PH or sham animals. As
Figure 7 shows, the serum obtained from animals 3 h after PH
induced a 4-fold increase in the CAT activity, and this effect was
lost when serum after 8 h of PH was used. Sera from sham
animals failed to significantly induce CAT activity. To investigate
the role of the jB motifs in the promoter activity, AT3F cells
were transfected with a promoter construct in which both jB
sites were mutated. As Figure 7(right) shows, under these
conditions the reporter activity was completely abrogated, indi-
cating an essential role of the jB sites for the expression of iNOS
in the course of PH. The effect of the PH serum was compared
with serum from animals treated with LPS at 3 and 6 h, resulting
in an important induction of the CAT activity when the jB sites
were functional (Figure 7, insets). Transfection with a construct
containing the thymidine kinase promoter spanning from nt
®105 bp to ­1 bp failed to express CAT activity in response to
serum from PH or LPS-treated animals (results not shown).
DISCUSSION
Liver regeneration after PH is characterized by the existence of
a precise temporal pattern of events that regulate entrance into
the division cell cycle, at the time when the organ basically
maintains its physiological functions [3]. In this regard, most of
the changes in the expression of immediate–early genes that
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follow PH [3,29] trigger the expression of proteins that directly
participate in the control of liver regeneration, either by pro-
moting cell growth or arrest [1,6], or by favouring the restoration
of blood flow and diffusion of extracellular factors that mediate
the synchronized regenerative process [8,9,30,31].
The induction of iNOS in liver in the course of several hepatic
dysfunctions, such as hyperdynamic circulation and chemical
aggression or during septic shock, appears to be a widely
established response of the damaged organ [12,32]. iNOS ex-
pression is mainly controlled at the transcriptional level [10,13],
and because of the synchrony of the regenerative process after
PH, we have investigated the nature of the transcription factors
responsible for the transactivation of this gene. Activation of
NF-jB has been reported as an essential requirement for iNOS
transcription [13,14]. In the remnant liver after PH, NF-jB
activation occurs at the start of the regenerative process (as soon
as 30 min post-PH), and rapidly falls in the hours following.
According to these data, it might be concluded that this early and
quantitatively important activation of NF-jB is sufficient to turn
on iNOS transcription, which exhibits a peak of mRNA levels
4 h after PH, and the corresponding peak of iNOS immuno-
reactivity at 8 h. However, in terms of the duration of NF-jB
activation, the requirements for iNOS expression could not be as
restricted, as reflected by the EMSA profile. Using higher
amounts of protein in EMSAs, FitzGerald et al. [33] reported the
presence of p50–p65 complexes (the transcriptionally active
molecules) 2 h after PH. Under our experimental conditions,
overexposure of the film confirmed the presence of the p50–p65
complex in 3-h post-PH samples, but it was completely absent in
6-h post-PH samples (results not shown). The requirement of
NF-jB activation for iNOS induction after PH was in agreement
with the absence of effect of post-PH serum upon an iNOS
promoter with mutated jB sites after transient transfection in a
PH-responsive hepatoma cell line. Moreover, using the jB sites
of the iNOS promoter, only two bands were detected in EMSAs
after PH, whereas a third band, termed supercomplex by other
groups [33,34], was reported when the sequence used for the
binding corresponded to the jB motif present in the promoter of
class I major histocompatibility complex H2 gene.
Our results also give information on the differential regulation
of IjB proteins between PH and LPS treatment. The biological
activity of the NF-jB}c-Rel proteins depends upon the in-
teraction with the inhibitory IjB proteins, and we observed a
prevalence of IjBa degradation after PH. IjBb levels largely
decreased after endotoxin treatment although, in samples
obtained at 3 h, a complete recovery of the protein level was
observed. This result is of interest because, using established cell
lines, other groups reported a long-sustained fall in IjBb upon
LPS stimulation [17]. At the mRNA level, the important up-
regulation of IjBa in animals treated with LPS could be related
with the corresponding protein levels, and the same applies to
IjBb after PH. These results might provide a plausible ex-
planation for the short-term activation of NF-jB after PH.
Activation of AP-1 following PH could be due to both an
induction of c-fos [35] and an activation of Jun kinase [36].
Interestingly, the pattern of AP-1 activation after PH and LPS
treatment was different. Whereas a progressive activation of AP-
1 was observed after PH, the opposite occurred in animals
treated with endotoxin. However, using deletional analysis of the
iNOS promoter and following the activity of a reporter gene,
agreement exists in proposing a minimal contribution of the AP-
1 sites to the transactivation of the gene [10,14,21].
Finally, IRF-1, which appears to be very important for the
expression of iNOS in macrophages and other cells [11,27,37], is
constitutively expressed in liver, and despite an increase in the
protein content after PH, we were unable to detect binding of
this factor to the corresponding motif using EMSAs of nuclear
extracts of the remnant liver. This result can be explained in view
of the important content of IRF-2 in liver, which inhibits the
activity of IRF-1 [27,37]. Moreover, in addition to the relative
amounts of IRF-1 and IRF-2, IRF-1 activity appears to be
qualitatively regulated by a yet-unidentified post-translational
mechanism that increases its intrinsic DNA binding affinity, as
has been described after some viral infections [27].
The function of NO in the regenerative process after PH
remains to be established. Inhibition of NO synthesis with more-
or-less specific pharmacological iNOS inhibitors resulted in an
enhanced superoxide production by liver [38], and in an altered
ploidy pattern in the remnant tissue [8]. Moreover, NO has
proved to be an important regulator of IjB function [39], and in
this way, it can prevent NF-jB activation once its synthesis is
turned on. In this aspect, NF-jB activation is largely delayed (at
least 3 h after PH; experiments in progress) in animals previously
treated with dexamethasone, a condition in which IjB activity is
up-regulated [40] and iNOS expression repressed [41]. In addition
to these ‘ intracellular ’ effects, NO may favour hepatic circulation
after hepatectomy, and contribute to the angiogenic activity in
the remnant liver. PH experiments in animals with disrupted
iNOS gene [42] could provide further clues to better understand
the role of iNOS expression in regenerating liver. Using this
genetic approach, in mice with targeted disruption of the
interleukin-6 gene, it has been possible to show a critical role for
this cytokine in liver regeneration [43].
In summary, our results support the conclusion that transient
activation of NF-jB after-PH is essential for the expression of
iNOS. Specific regulation of IjBa and IjBb activity after PH
may contribute to this transient expression of iNOS, a situation
different from that for animals treated with LPS.
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